TNF and inflammatory bowel disease: We here aimed in a fully human in vitro BBB model to investigate the actions of pioglitazone in restoring BBB homeostasis and preventing damage triggered by peripheral inflammatory factors, exploring such effects utilizing TNFα, a major cytokine released during peripheral inflammation, and plasma from IBD patients as a further source of peripheral inflammatory stimuli.